EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Electrochemotherapy as a symptom-oriented palliative treatment option: an exploratory single-center study in 15 patients with locally advanced or locoregionally recurrent vulvar carcinoma

Eva-Maria Grischke iD, Felix Neis iD, Ernst Oberlechner iD, Melanie Henes iD, Martin Weiß iD, Sara Y Brucker iD

Archives of Gynecology and Obstetrics · 14.01.2026 · 313 (1)

DOI: 10.1007/s00404-025-08296-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 14.01.2026. Verfasst von Eva-Maria Grischke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Tübingen, Calwerstr. 7, 72076, Tübingen, Germany. eva-maria.grischke@med.uni-tuebingen.de. Hauptthemen laut MEDLINE: Vulvar Neoplasms, Palliative Care, Electrochemotherapy, Neoplasm Recurrence, Local. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Tübingen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vulvar carcinoma (VC), a rare cancer, recurs in over a third of women, usually within 2 years. Treatment options other than repeat surgery and radiotherapy are often required in the recurrence setting. Systemic chemotherapy is an option but is generally associated with stressful side effects. In the palliative setting, electrochemotherapy (ECT) is a better-tolerated alternative, which provides local tumor control while obviating systemic side effects.

Objective

To descriptively analyze a case series of patients with inoperable locally advanced or locoregionally recurrent VC receiving bleomycin-based ECT.

Methods

Descriptive analysis of prospectively collected data from a case series. Postmenopausal women with locally advanced or locoregionally recurrent VC were eligible for inclusion. Bleomycin was administered at 15 mg/m 2 body surface as a single 1-min intravenous injection; 8 min later, electrochemical treatment using sterile disposable electrodes was performed under anesthesia for ≤ 30 min. Postoperatively, patients received pain medication to mitigate muscle soreness.

Results

15 patients were included in the study. Median patient age at ECT was 81 (range, 51–100) years. Recurrences (1–5) were present in 12 patients. Surgery and radiotherapy were not justifiable options in 3 patients. In our clinical observation, ECT was well tolerated by all patients for the management of pain, itching, odor, and secretion. This allowed for time to be gained until further treatment became necessary or disease progression occurred.

Conclusions

In our clinical experience, bleomycin-based ECT is an oncologically efficacious and better-tolerated alternative to systemic chemotherapy or immunotherapy in patients with recurrent VC in a palliative setting with limited capacity to undergo treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vulvar NeoplasmsPalliative CareElectrochemotherapyNeoplasm Recurrence, LocalBleomycinAntibiotics, AntineoplasticCarcinomaHumansFemaleMiddle AgedAgedAged, 80 and overProspective StudiesTreatment Outcome

Stichwörter der Autor:innen

ChemotherapyFemale external genitaliaFemale genital tractOncology

Substanzen

BleomycinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Tübingen, Calwerstr. 7, 72076, Tübingen, Germany. eva-maria.grischke@med.uni-tuebingen.de.
  • Department of Obstetrics and Gynecology, University of Tübingen, Calwerstr. 7, 72076, Tübingen, Germany.

ORCID-Profile: Eva-Maria Grischke, Felix Neis, Ernst Oberlechner, Melanie Henes, Martin Weiß, Sara Y Brucker

Förderung

  • Universitätsklinikum Tübingen

Zitieren

APA

Grischke, E. M., Neis, F., Oberlechner, E., Henes, M., Weiß, M., & Brucker, S. Y. (2026). Electrochemotherapy as a symptom-oriented palliative treatment option: an exploratory single-center study in 15 patients with locally advanced or locoregionally recurrent vulvar carcinoma. Archives of Gynecology and Obstetrics, 313(1). https://doi.org/10.1007/s00404-025-08296-w

Vancouver

Grischke EM, Neis F, Oberlechner E, Henes M, Weiß M, Brucker SY. Electrochemotherapy as a symptom-oriented palliative treatment option: an exploratory single-center study in 15 patients with locally advanced or locoregionally recurrent vulvar carcinoma. Archives of Gynecology and Obstetrics. 2026;313(1). doi:10.1007/s00404-025-08296-w

BibTeX
@article{Grischke2026,
  author = {Grischke, Eva-Maria and Neis, Felix and Oberlechner, Ernst and Henes, Melanie and Weiß, Martin and Brucker, Sara Y},
  title = {Electrochemotherapy as a symptom-oriented palliative treatment option: an exploratory single-center study in 15 patients with locally advanced or locoregionally recurrent vulvar carcinoma},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2026},
  volume = {313},
  number = {1},
  doi = {10.1007/s00404-025-08296-w}
}
Kostenlos starten →